<DOC>
	<DOC>NCT02776384</DOC>
	<brief_summary>The study aims to investigate whether disease progression in patients with chronic heart failure (CHF) can be assessed by new biomarkers, and determine their diagnostic value. The study also intends to describe comparison of echocardiography with cardiopulmonary function test in CHF patients, and relating these cardiac functional parameters to clinical outcome.</brief_summary>
	<brief_title>Prognostic and Diagnostic Value of Biomarkers and Cardiac Functional Parameters in Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age ≥18 years with symptoms and signs in NYHA Ⅱ~Ⅳ with cardiac structural changes confirmed by echocardiography with other severe diseases combined and will be alive for less than 12 months hard to participate in the investigation or accept the followup visits pregnant or lactating women during the acute phase of STelevation acute myocardial infarction, stroke, severe infection and other critical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Cardiopulmonary Function Tests</keyword>
</DOC>